115379 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12932)
  10. Department of Pathology and Laboratory Medicine (12602)
Formats
  1. Journal Article (66748)
  2. Meeting Abstract (33628)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39026)
  2. GSK Faculty (22463)
  3. Solid Tumor Oncology Division (22051)
  4. Surgery (21243)
  5. Sloan Kettering Institute Faculty (16084)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1224)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1983)
  2. 2024 (5385)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial differences in organic anion transport proteins (OATP) and outcome in castration resistant prostate cancer treated with AR pathway inhibitors in Alliance A031201: A phase III trial
    Meeting Abstract

    Ryan, C. J.; Kim, H.; Morris, M. J.; Alyamani, M.; Diaz, R.; Beltran, H.; Armstrong, A. J.; Sharifi, N.; Halabi, S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Preferred treatment regimens for rare genitourinary (GU) malignancies
    Meeting Abstract

    Simon, N. I.; Berg, S. A.; Tan, A.; Chandran, E.; Atiq, S. O.; Kydd, A. R.; Cordes, L. M.; Mortazavi, A.; Reimers, M. A.; Milowsky, M. I.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Cognitive effects of androgen receptor (AR) directed therapies for advanced cancer of the prostate (COGCaP): A comparison of enzalutamide vs abiraterone acetate
    Meeting Abstract

    Morgans, A. K.; Ma, Y.; Jackson, J. C.; Ryan, C. J.; Moses, K. A.; Barata, P. C.; Dorff, T. B.; Kocherginsky, M.; Vanderweele, D. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world treatment pattern and clinical outcomes among patients with metastatic renal cell (mRCC) carcinoma post PD-1/PD-L1 immuno-oncology (IO) therapies
    Meeting Abstract

    Shah, N. J.; Ravilla, R.; Osterland, A. J.; Todoroff, K.; Wang, C. Y.; Rane, P.; Saal, H.; Wang, D.; Motzer, R. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • National cancer system characteristics and prostate cancer outcomes: A global analysis
    Meeting Abstract

    Dee, E. C. C.; Iyengar, R.; Narayan, A.; Feliciano, E. J. G.; Nagar, H.; Mahal, B. A.; Nguyen, P. L.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Incidence and mortality trends in genitourinary cancer in Southeast Asia from 1990-2021
    Meeting Abstract

    Columbres, R. C. A.; Selokar, A.; Sha, S.; Ranganathan, S.; Wu, J. F.; Feliciano, E.; Mahal, B. A.; Nguyen, P. L.; Dee, E. C. C.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A liquid biopsy-based proteomic assay to identify circulating tumor cell (CTC) -derived druggable targets in cancer patients
    Meeting Abstract

    Horrmann, A.; Arafa, A.; Kamalanathan, K.; Hesch, A.; Schaap, G.; Izuora, Z.; Ahmadi, M.; Konety, B. R.; Scher, H. I.; Antonarakis, E. S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-world community oncology-based treatment patterns for first line axitinib plus pembrolizumab in advanced renal cell carcinoma: Initial dosing, dose reductions and clinical outcomes
    Meeting Abstract

    Zarrabi, K. K.; Ababio, Y.; Eccleston, A.; Rao, Drnj; Kelly, S.; Chang, J. E.; Adejumo, K. L.; Lucht, S.; Paydar, C.; Van Doren, B. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Adrenal androgens and overall survival (OS) in men with castration-resistant prostate cancer (CRPC) treated with enzalutamide without (ENZ) or with abiraterone and prednisone (ENZ/AAP) (Alliance)
    Meeting Abstract

    Sharifi, N.; Kim, H.; Alyamani, M.; Diaz, R.; Beltran, H.; Armstrong, A. J.; Morris, M. J.; Halabi, S.; Ryan, C. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • AI-driven prediction of prostate cancer risk: A comparative analysis with C the Signs in the Mayo Clinic data platform
    Meeting Abstract

    Bakshi, B.; Raoof, S.; Haddad, T. C.; Patel, T.; Ryan, C. J.; Riaz, I. B.; Dadhania, S.; Herrick, B.; Payling, M.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save